Literature DB >> 7655346

Expression of human metallothionein-III in transgenic mice.

J C Erickson1, B A Masters, E J Kelly, R L Brinster, R D Palmiter.   

Abstract

Transgenic mice that express human metallothionein-III (hMT-III) were generated. Human MT-III mRNA expression was prominent in brain, resulting in a 9-fold elevation of MT-III mRNA in cortex, a 3-5-fold elevation in hippocampus, thalamus, brainstem, and olfactory bulb, and a 1.4-fold elevation in cerebellum. Human MT-III protein was detected biochemically and accounted for a 3.4-fold increase in total brain MT. The concentration of zinc (but not copper) was elevated in those brain regions that expressed the most hMT-III mRNA. The histochemically reactive pool of zinc, as measured by Timm's stain or TS-Q histofluorescence, was not appreciably altered. No changes in brain weight, morphology or histology have been noted; the mice breed normally and appear to have normal behavior.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7655346     DOI: 10.1016/0197-0186(94)00166-r

Source DB:  PubMed          Journal:  Neurochem Int        ISSN: 0197-0186            Impact factor:   3.921


  9 in total

1.  Characterization of the role of metallothionein-3 in an animal model of Alzheimer's disease.

Authors:  Yasmina Manso; Javier Carrasco; Gemma Comes; Gabriele Meloni; Paul A Adlard; Ashley I Bush; Milan Vašák; Juan Hidalgo
Journal:  Cell Mol Life Sci       Date:  2012-06-22       Impact factor: 9.261

Review 2.  Metallothionein in the central nervous system: Roles in protection, regeneration and cognition.

Authors:  Adrian K West; Juan Hidalgo; Donnie Eddins; Edward D Levin; Michael Aschner
Journal:  Neurotoxicology       Date:  2008-01-19       Impact factor: 4.294

3.  Evidence for a high molecular weight cytosolic factor that binds brain and liver metallothionein.

Authors:  T Gasull; J Hidalgo
Journal:  Neurochem Res       Date:  1996-08       Impact factor: 3.996

4.  Identification of mouse brain proteins associated with isoform 3 of metallothionein.

Authors:  David W Lahti; John D Hoekman; Abigail M Tokheim; Bruce L Martin; Ian M Armitage
Journal:  Protein Sci       Date:  2005-03-31       Impact factor: 6.725

5.  Disruption of the metallothionein-III gene in mice: analysis of brain zinc, behavior, and neuron vulnerability to metals, aging, and seizures.

Authors:  J C Erickson; G Hollopeter; S A Thomas; G J Froelick; R D Palmiter
Journal:  J Neurosci       Date:  1997-02-15       Impact factor: 6.167

6.  Metallothionein-3 and neuronal nitric oxide synthase levels in brains from the Tg2576 mouse model of Alzheimer's disease.

Authors:  Bruce L Martin; Abigail M Tokheim; Patrick T McCarthy; Brendan S Doms; Andrew A Davis; Ian M Armitage
Journal:  Mol Cell Biochem       Date:  2006-02       Impact factor: 3.396

7.  Metallothioneins and brain injury: What transgenic mice tell us.

Authors:  Juan Hidalgo
Journal:  Environ Health Prev Med       Date:  2004-05       Impact factor: 3.674

8.  Elimination of zinc from synaptic vesicles in the intact mouse brain by disruption of the ZnT3 gene.

Authors:  T B Cole; H J Wenzel; K E Kafer; P A Schwartzkroin; R D Palmiter
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-16       Impact factor: 11.205

Review 9.  A role for synaptic zinc in ProSAP/Shank PSD scaffold malformation in autism spectrum disorders.

Authors:  Andreas M Grabrucker
Journal:  Dev Neurobiol       Date:  2013-09-11       Impact factor: 3.964

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.